Bluejay Diagnostics Inc (BJDX)

bjdx..................................p/m

The Bluejay is flying high today on the news

Bluejay Diagnostics Clears Prefunded Warrants After Full ExerciseFebruary 20, 2026 9:44 AM
IH Market News
Bluejay Diagnostics (NASDAQ:BJDX) said it has completed the full exercise of all prefunded warrants issued in its October 2025 private placement, eliminating any remaining prefunded warrants as of February 19.Following the conversions, the company now has roughly 972,000 shares of common stock outstanding. Shares were recently trading at $1.99, close to their 52-week low of $1.86, marking a steep decline of about 86% over the past 12 months.Bluejay still has outstanding cash-exercisable warrants tied to approximately 1.5 million shares, each with an exercise price of $7.00 or higher.The company also noted that several recent Schedule 13G filings do not reflect its 1-for-4 reverse stock split implemented on January 29, 2026. As a result, reported beneficial ownership figures may appear inflated because they are shown on a pre-split basis.Bluejay is developing its Symphony System, a near-patient diagnostic platform designed for sepsis triage and monitoring. The system has not yet received regulatory clearance, and U.S. commercialization will require approval from the Food and Drug Administration.With a market capitalization of roughly $0.9 million, the company remains in the pre-revenue stage. While it holds more cash than debt, it continues to consume cash at a rapid pace — a key factor for investors evaluating its financial position.Bluejay’s lead product candidate is an interleukin-6 (IL-6) test intended to deliver results in approximately 20 minutes.In a separate update, the company recently confirmed it has completed commercial-scale production of IL-6-targeting antibodies for use in its Symphony cartridges. The antibodies have met internal performance benchmarks and are expected to support ongoing clinical testing and future commercialization efforts.Bluejay also implemented the previously announced 1-for-4 reverse stock split effective January 29, 2026. The company’s shares continue to trade on the Nasdaq Capital Market under the same ticker symbol, though with a new CUSIP number.Bluejay Diagnostics stock price

Original: Bluejay Diagnostics Clears Prefunded Warrants After Full Exercise

BJDX POST RS IS READY TO GO

BJDX NEXT POST RS ROUND

BJDX post RS bio beast

I highly doubt shorts will be dumb enough to home $LRHC and $BJDX low floater stocks with pending news but I have been wrong before

$4.80 One year anniversary pump no sales just agreement for equipment will dump fast

BJDX..................................https://stockcharts.com/h-sc/ui?s=BJDX&p=W&b=5&g=0&id=p86431144783

Strong on pre-market!

this one looks like it may squeeze up, super low float 1.49 million shares. hit a high of 12$ last run!!!

BJDX.................................................................https://stockcharts.com/h-sc/ui?s=BJDX&p=W&b=5&g=0&id=p86431144783

BJDX.................................................................................................p/m

BJDX........................................https://stockcharts.com/h-sc/ui?s=BJDX&p=W&b=5&g=0&id=p86431144783

As of April 28, 2025, there were 1,494,167 shares of the registrant’s common stock outstanding

Still looks fantastic!😍

$BJDX Shares Outstanding 554 K 🚀🚀🚀

New roket

BJDX, new 52 week low

BJDX......................https://stockcharts.com/h-sc/ui?s=BJDX&p=W&b=5&g=0&id=p86431144783

bjdx.....................................................................p/m

$6 + 50%

$6s boom 500knfloat

BJDX MONSTER PLAY AND NOBODY SAW IT

$9 + 132% cash some out

On December 3, 2024, Bluejay Diagnostics, Inc. (the “Company”) received a letter from the Listing Qualifications Department of The Nasdaq Stock Market notifying the Company that, based on the closing bid price of the Company’s common stock having been at least $1.00 per share for the required period, the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2) and the minimum bid price deficiency matter previously disclosed by the Company on March 4, 2024 is now closed.

Another 500k floater $5,72 + 46%

BJDX...THTA 6.25 LOOKS RIGHT

BJDX SHES OFF AND RUNNING

BJDX SECOND RS CAN BE GOOD ONES

BJDX.........................https://stockcharts.com/h-sc/ui?s=BJDX&p=W&b=5&g=0&id=p86431144783

BJDX MICRO NASY POS PLAY..SCALP IT

insane volume.

Nice pump before reverse split 

BJDX.........................https://stockcharts.com/h-sc/ui?s=BJDX&p=W&b=5&g=0&id=p86431144783

Proposal 1. Approval and adoption of an amendment to the Company’s amended and restated certificate of incorporation, as amended, to effect a reverse stock split of the Company’s common stock - The Company’s stockholders approved and adopted an amendment to the Company’s certificate of incorporation to effect a reverse stock split of all of the Company’s outstanding shares of common stock by one of several fixed ratios between 1-for-20 and 1-for-50 (the “Reverse Stock Split”). The voting results for the proposal were as follows:

In with a starter, will be buying .07s if they become available

Reverse split to be voted and approved Oct 23 1pm

Great Vol. Today !!

Seems ready

Anytime ready

Okay thanks

Yup, r/s coming soon - Pre 14A dropped Friday

Super rebound next week?

.18 dip

.19 dip

August 28, 2024, Nasdaq’s Listing Qualifications Staff notified the Company that it has extended the time period for the Company to regain compliance with the Minimum Bid Requirement until February 24, 2025. To regain compliance, the closing bid price of the Common Stock must be at least $1.00 or higher for a minimum of ten consecutive business days.

The Company intends to continue to actively monitor the closing bid price of the Common Stock and will evaluate available options to regain compliance with the Minimum Bid Requirement. Specifically, the Company has confirmed to Nasdaq that, if necessary, it will implement a reverse stock split of its outstanding common stock (if approved by the Company’s stockholders) to attempt to regain compliance. If the Company does not regain compliance within the additional compliance period, Nasdaq will provide notice that the Common Stock will be subject to delisting. The Company would then be entitled to appeal that determination to a Nasdaq hearings panel. There can be no assurance that the Company will regain compliance with the Minimum Bid Requirement during the 180-day additional compliance period or maintain compliance with the other Nasdaq listing requirements.

3.6m shares traded whole float interesting

Hedgies loading down here News must be around the corner. Unusual volume

Pounded down by hedgies no mercy .. . Last offering at $1.63 long ways up..
The purchase price of each Common Unit is $1.63, and the purchase price of each Prefunded Unit is $1.6299 (which is equal to the public offering price per Common Unit minus $0.0001). The Prefunded Warrants will be immediately exercisable and may be exercised at any time until all the Prefunded Warrants are exercised in full.
The Class C Warrants, which will not be exercisable until approval by the Company’s stockholders, will have an initial exercise price of $1.96 per share, and will expire five (5) years from the date of such stockholder approval. Each Class D Warrant will be exercisable immediately. The exercise price and number of shares of Common Stock issuable under the Class D Warrants are subject to adjustment as described in the Class D Warrant. The Company intends to use the net proceeds from the offering to (i) repay $2.3 million in outstanding debt that will be due and payable upon consummation of the offering and (ii) fund matters related to obtaining FDA approval (including clinical studies related thereto), as well as for other research and development activities, and for general working capital needs.

Bottom feeder at .20-.22 let’s go some still relatively low floater

Any possible catalyst?